Drug–Drug and Drug–Natural Compound Interactions: From Bench to Bedside
A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Pharmaceutical Science".
Deadline for manuscript submissions: closed (21 April 2023) | Viewed by 3381
Special Issue Editors
Interests: drug/drug interaction; metabolic syndrome; natural compounds
Special Issues, Collections and Topics in MDPI journals
Interests: clinical trials; new drug development; drug/drug(food) interaction; pharmacokinetics
Special Issues, Collections and Topics in MDPI journals
Interests: microRNA; anticancer drugs; circulating biomarkers; marine compounds; natural compounds; melanoma
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
To reduce the adverse effect and enhance the treatment efficacy, a series of drug combination is frequently applied for treatment of metabolic syndrome and cancers. Moreover, patients with metabolic syndrome or cancers usually take herbal supplements for remission of symptoms. Several studies observed that combination of the chemotherapeutic drugs or drug/natural compounds has additional therapeutic efficacies than drug or natural compounds alone. However, several studies also demonstrated that patients receiving drug/drug combination or drug/natural compounds combination experience unexpected adverse effects whereas which underlying mechanism is still elusive. This Special Issue intends to collect any studies, including research articles for evaluating new synergistic combination and their synergistic mechanisms, systemic reviews for evaluating potential drug/drug toxicity, or clinical trials for assessing the putative populations experiencing drug/drug synergism or toxicities.
Dr. Shian-Ren Lin
Prof. Dr. Ju-Seop Kang
Prof. Dr. Paola Nieri
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- synergism
- drug interaction
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
